Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 March 2026 - 14:25

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 4, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/vyloy

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters